STAT

In expert panel, FDA says ‘door is open’ for testosterone labeling revisions

Exactly a month after it announced the removal of black box warning labels on estrogen therapy products used in menopause, the Food and Drugs ...
STAT

Solicitor general urges Supreme Court to review ‘skinny labeling’ and generic drug access

In a closely watched case, the U.S. solicitor general has urged the Supreme Court to review a controversy over so-called ...
Le Lézard

UCB presents positive results from GEMZ phase 3 study at AES showing fenfluramine significantly reduced countable motor seizure frequency in CDKL5 deficiency disorder

UCB, a global biopharmaceutical company, today presented positive efficacy and safety results from the GEMZ phase 3 study investigating adjunctive fenfluramine (FFA) in children and adults with CDKL5 ...
The Malaysian Reserve

Sumitomo Pharma America Presents New Investigational Data on Enzomenib and Nuvisertib at the 2025 American Society of Hematology Annual Meeting and Exposition

New investigational data from Phase 1/2 study of enzomenib (DSP-5336) in patients with relapsed/refractory acute myeloid leukemia (AML) show clinical ...